Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001654954-25-010214
Filing Date
2025-08-29
Accepted
2025-08-29 16:16:51
Documents
26
Effectiveness Date
2025-08-29

Document Format Files

Seq Description Document Type Size
1 FORM S-8 cvm_s8.htm S-8 74872
2 2025 NON-QUALIFIED STOCK OPTION PLAN cvm_ex4b.htm EX-4.(B) 20967
3 2025 STOCK BONUS PLAN cvm_ex4c.htm EX-4.(C) 34899
4 OPINION cvm_ex5.htm EX-5 7406
5 CONSENT cvm_ex231.htm EX-23.1 4008
6 CONSENT cvm_ex232.htm EX-23.2 2318
7 ADDITIONAL EXHIBITS cvm_ex99.htm EX-99 170739
8 FILING FEE cvm_ex107.htm   iXBRL EX-FILING FEES 42609
9 cvm_ex99img20.jpg GRAPHIC 36442
10 cvm_ex99img19.jpg GRAPHIC 32017
11 cvm_ex99img18.jpg GRAPHIC 39307
12 cvm_ex99img17.jpg GRAPHIC 30460
13 cvm_ex99img16.jpg GRAPHIC 22102
14 cvm_ex99img15.jpg GRAPHIC 22137
15 cvm_ex99img10.jpg GRAPHIC 19782
  Complete submission text file 0001654954-25-010214.txt   758864

Data Files

Seq Description Document Type Size
29 EXTRACTED XBRL INSTANCE DOCUMENT cvm_ex107_htm.xml XML 4715
Mailing Address 8229 BOONE BLVD. SUITE 802 VIENNA VA 22182
Business Address 8229 BOONE BLVD . SUITE 802 VIENNA VA 22182 7035069460
CEL SCI CORP (Filer) CIK: 0000725363 (see all company filings)

EIN.: 840916344 | State of Incorp.: CO | Fiscal Year End: 0930
Type: S-8 | Act: 33 | File No.: 333-289945 | Film No.: 251281105
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)